Transduction pathways for noradrenaline-induced modulation of calcium channels in vascular smooth muscle.
Mironneau
J
J
Laboratoire de Physiologie Cellulaire et Pharmacologie Moléculaire, Université de Bordeaux II, France.
D000818:Animals; D002121:Calcium Channel Blockers / Q000378:metabolism; D015220:Calcium Channels / Q000187:drug effects*; D004095:Dihydropyridines / Q000378:metabolism; D004594:Electrophysiology; D006736:Horses; D066298:In Vitro Techniques; D017275:Isradipine; D008566:Membranes / Q000187:drug effects / Q000378:metabolism; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology*; D010716:Phosphatidylinositols / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects*
D002121:Calcium Channel Blockers; D015220:Calcium Channels; D004095:Dihydropyridines; D010716:Phosphatidylinositols; D011493:Protein Kinase C; D009638:Norepinephrine; D017275:Isradipine